Trypanosoma cruzi-triggered meningoencephalitis is a CCR1/CCR5-independent inflammatory process

Journal of Neuroimmunology

Volumn 184, Issue 1-2, 2007, Pages 156-163

  Silva, Andréa Alice ^a,b   Roffê, Ester ^c   Santiago, Helton ^a   Marino, Ana Paula ^a   Kroll Palhares, Karina ^a   Teixeira, Mauro Martins ^c   Gazzinelli, Ricardo Tostes ^a,c   Lannes Vieira, Joseli ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chemokines; Meningoencephalitis; Met RANTES; Trypanosoma cruzi

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; MESSENGER RNA; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENCEPHALITIS; HUMAN; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PARASITISM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; ANTIGENS, CD8; CELL MOVEMENT; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MENINGOENCEPHALITIS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; RANTES; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; TRYPANOSOMA CRUZI;

EID: 33847793465     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.12.013     Document Type: Article

References (29)

1. Aliberti J.C., Machado F.S., Souto J.T., Campanelli A.P., Teixeira M.M., Gazzinelli R.T., and Silva J.S. beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosom cruzi. Infect. Immun. 67 9 (1999) 4819-4826
2. Antunes A.C., Cecchini F.M., Bolli F.B., Oliveira P.P., Reboucas R.G., Monte T.L., and Fricke D. Cerebral trypanosomiasis and AIDS. Arq. Neuro-Psiquiatr. 60 3-B (2002) 730-733
3. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J. Exp. Med. 115 (1962) 453-466
4. Cartier L., Hartley O., Dubois-Dauphin M., and Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 48 1 (2005) 16-42
5. Cook D.N., Smithies O., Strieter R.M., Frelinger J.A., and Serody J.S. CD8+ T cells are a biologically relevant source of macrophage inflammatory protein-1 alpha in vivo. J. Immunol. 162 9 (1999) 5423-5428
6. Da Matta J.R., Camargos M.R., Chiari E., and Machado C.R. Trypanosoma cruzi infection and the rat central nervous system: proliferation of parasites in astrocytes and the brain reaction to parasitism. Brain Res. Bull. 53 2 (2000) 153-162
7. Diedrichs-Mohring M., Nelson P.J., Proudfoot A.E., Thurau S.R., and Wildner G. The effect of the CC chemokine receptor antagonist Met-RANTES on experimental autoimmune uveitis and oral tolerance. J. Neuroimmunol. 164 1-2 (2005) 22-30
8. dos Santos P.V., Roffê E., Santiago H.C., Torres R.A., Marino A.P., Paiva C.N., Silva A.A., Gazzinelli R.T., and Lannes-Vieira J. Prevalence of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes Infect. 3 12 (2001) 971-984
9. dos Santos A.C., Barsante M.M., Esteves Arantes R.M., Bernard C.C., Teixeira M.M., and Carvalho-Tavares J. CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis-an intravital microscopy study. J. Neuroimmunol. 162 1-2 (2005) 122-129
10. Glass W.G., and Lane T.E. Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system. Virology 312 2 (2003) 407-414
11. Glass W.G., Hickey M.J., Hardison J.L., Liu M.T., Manning J.E., and Lane T.E. Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J. Immunol. 172 7 (2004) 4018-4025
12. Jardim E., and Takayanagui O.M. Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient. J. Trop. Méd. Hyg. 97 6 (1994) 367-370
13. Luster A.D., Alon R., and von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 6 12 (2005) 1182-1190
14. Machado F.S., Martins G.A., Aliberti J.C., Mestriner F.L., Cunha F.Q., and Silva J.S. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation 102 24 (2000) 3003-3008
15. Marino A.P., Azevedo M.I., and Lannes-Vieira J. Differential expression of adhesion molecules shaping the T-cell subset prevalence during the early phase of autoimmune and Trypanosoma cruzi-elicited myocarditis. Mem. Inst. Oswaldo Cruz 98 7 (2003) 945-952
16. Marino A.P., da Silva A., dos Santos P., Pinto L.M., Gazzinelli R.T., Teixeira M.M., and Lannes-Vieira J. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 110 11 (2004) 1443-1449
17. Marino A.P., Silva A.A., Santos P.V., Pinto L.M., Gazinelli R.T., Teixeira M.M., and Lannes-Vieira J. CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis. Mem. Inst. Oswaldo Cruz 1 (2005) 93-96
18. Matsui M., Weaver J., Proudfoot A.E., Wujek J.R., Wei T., Richer E., Trapp B.D., Rao A., and Ransohoff R.M. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES. J. Neuroimmunol. 128 1-2 (2002) 16-22
19. Michailowsky V., Silva N.M., Rocha C.D., Vieira L.Q., Lannes-Vieira J., and Gazzinelli R.T. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am. J. Pathol. 159 5 (2001) 1723-1733
20. Moser B., and Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2 2 (2001) 123-128
21. Nansen A., Marker O., Bartholdy C., and Thomsen A.R. CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection. Eur. J. Immunol. 30 7 (2000) 1797-1806
22. Pittella J.E. Central nervous system involvement in Chagas' disease. An updating. Rev. Inst. Med. Trop. Sao Paulo 35 2 (1993) 111-116
23. Proudfoot A.E., Power C.A., Hoogewerf A.J., Montjovent M.O., Borlat F., Offord R.E., and Wells T.N. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J. Biol. Chem. 271 5 (1996) 2599-2603
24. Rocha A., de Meneses A.C., da Silva A.M., Ferreira M.S., Nishioka S.A., Burgarelli M.K., Almeida E., Turcato Junior G., Metze K., and Lopes E.R. Pathology of patients with Chagas' disease and acquired immunodeficiency syndrome. Am. J. Trop. Med. Hyg. 50 3 (1994) 261-268
25. Roffê E., Silva A.A., Marino A.P., dos Santos P.V., and Lannes-Vieira J. Essential role of VLA-4/VCAM-1 pathway in the establishment of CD8+ T-cell-mediated Trypanosom cruzi-elicited meningoencephalitis. J. Neuroimmunol. 142 1-2 (2003) 17-30
26. Silva A.A., Roffê E., Marino A.M.P., dos Santos P.V., Quirico-Santos T., Paiva C.N., and Lannes-Vieira J. Chagas' disease encephalitis: intense CD8+ lymphocytic infiltrate is restricted to the acute phase, but is not related to the presence of Trypanosoma cruzi antigens. Clin. Immunol. 92 1 (1999) 56-66
27. Talvani A., Ribeiro C.S., Aliberti J.C., Michailowsky V., Santos P.V., Murta S.M., Romanha A.J., Almeida I.C., Farber J., Lannes-Vieira J., Silva J.S., and Gazzinelli R.T. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect. 2 8 (2000) 851-866
28. Teixeira M.M., Gazzinelli R.T., and Silva J.S. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol. 18 6 (2002) 262-265
29. Trifilo M.J., Bergmann C.C., Kuziel W.A., and Lane T.E. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection. J. Virol. 77 7 (2003) 4004-4014